Compositions and methods for imaging and treatment
US-9849194-B2 · Dec 26, 2017 · US
US2016367705A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016367705-A1 |
| Application number | US-201615184822-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jun 16, 2016 |
| Priority date | Jun 16, 2015 |
| Publication date | Dec 22, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to relates to a nanoparticle that includes a shell formed from a first monomer having a first charge and a second monomer different than the first monomer. The first and second monomers are copolymerized, and the shell encapsulates a core region and is associated with a charged entity having a second charge of opposite sign to the first charge. The present invention further relates to a nanoparticle having a neutral charge. The present invention further relates to nanoparticle dispersions, methods of making the nanoparticle, methods of method of imaging, methods of delivering drugs, and methods of delivering a high concentration of contrast enhancing and/or imaging agents.
Opening claim text (preview).
1 . A nanoparticle comprising: a shell formed from a first monomer having a first charge and a second monomer different than the first monomer, said first and second monomers being copolymerized, wherein said shell encapsulates a core region and is associated with a charged entity having a second charge of opposite sign to the first charge. 2 . The nanoparticle of claim 1 , wherein the charged entity is derived from a surfactant. 3 . The nanoparticle of claim 2 , wherein the charged entity is derived from a cationic surfactant selected from the group consisting of C 12 -C 18 alkyl dimethylammonium acetamide, C 12 -C 18 alkyl trimethylammonium, and mixtures thereof. 4 . The nanoparticle of claim 1 , wherein the charged entity is a charged substituent. 5 . The nanoparticle of claim 4 , wherein the charged substituent is a metal selected from the group consisting of silver, gold, copper, platinum, iron, manganese, cobalt, and mixtures thereof. 6 . The nanoparticle of claim 1 , wherein the first monomer and the second monomer are covalently linked. 7 . The nanoparticle of claim 1 , wherein the first charge is negative and the second charge is positive. 8 . The nanoparticle of claim 1 , wherein the first charge is positive and the second charge is negative. 9 . (canceled) 10 . The nanoparticle of claim 1 , wherein the first monomer is a deprotonated sugar acid comprising three or more hydroxyl groups. 11 . The nanoparticle of claim 1 , wherein the first monomer is selected from the group consisting of carboxylic acids, amines, alcohols, thiols, aldehydes, ketones, ethers, esters, nitriles, imides, or any salt thereof. 12 . (canceled) 13 . The nanoparticle of claim 1 , wherein the ratio of the first monomer to the charged entity is in the range of 3:1 to 1:3. 14 . The nanoparticle of claim 1 , wherein the nanoparticle is a hyperbranched polymeric nanoparticle. 15 . The nanoparticle of claim 1 , wherein the nanoparticle is a reticulated capsule. 16 . The nanoparticle of claim 1 , where the core region contains a core material selected from the group consisting of water, organic molecules, dye molecules, drugs, inorganic ions, organic ions, water soluble species, metals, and combinations thereof. 17 .- 23 . (canceled) 24 . A nanoparticle comprising: a shell formed from a first monomer and a second monomer different from the first monomer, said first and second monomer being copolymerized, wherein said shell encapsulates a core region and has a neutral charge. 25 .- 26 . (canceled) 27 . A dispersion comprising: the nanoparticle of claim 1 and a medium selected from the group consisting of water, methanol, dimethyl sulfoxide, chloroform, methylene chloride, and mixtures thereof, wherein the nanoparticle is dispersed in the medium. 28 . A method of making a nanoparticle, said method comprising: providing a first monomer having a first charge; providing a charged entity having a second charge of opposite sign to the first charge; contacting the first monomer with the charged entity in an aqueous medium under conditions effective to form a complex where the first monomer is associated with the charged entity; providing a second monomer; and contacting the complex with the second monomer under conditions effective to form a shell of the first and second monomers which have been copolymerized, said shell encapsulating a core region containing an aqueous medium. 29 .- 38 . (canceled) 39 . A method of imaging comprising: providing the nanoparticle of claim 1 , wherein the nanoparticle encapsulates an imaging agent in the core region; providing a subject to be imaged; administering the nanoparticle to said subject; and conducting an imaging procedure on said subject to which the nanoparticles have been administered. 40 .- 44 . (canceled) 45 . A method of delivering drugs, said method comprising: providing the nanoparticle of claim 1 with a drug encapsulated in the core; providing a subject to be treated; and administering to a subject the nanoparticle under conditions effective to deliver drugs. 46 . A method of delivering a high concentration of contrast enhancing and/or imaging agents, said method comprising: providing the nanoparticle of claim 1 with a contrast enhancing and/or imaging agent encapsulated in the core; providing a subject to be treated; and administering to the subject the nanoparticle.
Organic compounds, e.g. fats, sugars · CPC title
obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides · CPC title
the organic macromolecular compound being obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. PLGA · CPC title
Inorganic compounds · CPC title
Processes · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.